NURIX THERAPEUTICS, INC.: cashflow_financing

Value{"amount": 20041000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2025-12-01 – 2026-05-31
Statuscurrent
EntityNURIX THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001549595-26-000040 · Open the official SEC filing →
Retrieved: 2026-08-19T15:43:23.910780+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001549595/cashflow-financing/2026-05-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/c62c58e8-622b-41c1-8d6f-7a2f0dfa2fea

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies